Theravance Biopharma Cash Conversion Cycle 2011-2026 | TBPH

Annual Cash Conversion Cycle Theravance Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-4.54 K	882	1.4 K	-368	303	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.4 K	-4.54 K	-466

Quarterly Cash Conversion Cycle Theravance Biopharma

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.13	0.73	0.39	6.27	3.6	4.41	2.41	15.8	45.5	48.1	58.6	42.9	10.4	3.09	10.8	6.36	45	16.4	24.6	4.94	18.4	4.16	8.87	23.6	104	757	3.63 K	413	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.63 K	0.13	190

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 9.13	-0.76 %	$ 591 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-400	$ 0.91	2.42 %	$ 6.69 M	China
Edesa Biotech EDSA	97.1	$ 15.52	-2.39 %	$ 49.6 M	USA
ACADIA Pharmaceuticals ACAD	257	$ 22.47	1.19 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Fortress Biotech FBIO	-74.9	$ 2.24	0.9 %	$ 62.5 M	USA
Galapagos NV GLPG	67.1	$ 28.07	0.75 %	$ 2.69 B	Belgium
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	0.000171	$ 8.2	3.6 %	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	20.4	$ 31.01	-0.13 %	$ 1.78 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
ImmuCell Corporation ICCC	213	$ 8.44	-	$ 76.2 M	USA
Immuron Limited IMRN	867	$ 0.83	3.44 %	$ 6.55 M	Australia
Incyte Corporation INCY	-54.7	$ 98.87	-0.23 %	$ 19.3 B	USA
InMed Pharmaceuticals INM	184	$ 0.71	1.28 %	$ 1.74 M	Canada
INmune Bio INMB	19.9 K	$ 1.35	1.5 %	$ 33.4 M	USA
Innoviva INVA	24.6	$ 23.13	0.35 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Jaguar Health JAGX	289	$ 7.55	-4.13 %	$ 17.6 M	USA
KalVista Pharmaceuticals KALV	-816	$ 26.67	-0.02 %	$ 1.44 B	Britain
Kamada Ltd. KMDA	163	$ 8.15	0.49 %	$ 260 M	Israel
Ligand Pharmaceuticals Incorporated LGND	77.8	$ 223.98	-0.39 %	$ 4.1 B	USA
Liquidia Corporation LQDA	65.5	$ 38.39	0.62 %	$ 3.3 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Aquestive Therapeutics AQST	-172	$ 4.08	0.74 %	$ 436 M	USA